VYNE THERAPEUTICS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.71 USD | +3.44% |
|
+3.04% | +16.31% |
| May. 06 | VYNE Therapeutics Says US FDA Clears its Investigational New Drug Application for Potential Autoimmune Treatment | MT |
| Apr. 04 | Transcript : VYNE Therapeutics Inc. - Special Call |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-05-01 | 2024-05-02 | 2024-05-03 | 2024-05-06 | |
|---|---|---|---|---|
| Last | 2.53 $ | 2.5 $ | 2.62 $ | 2.71 $ |
| Volume | 83 588 | 29 242 | 34 681 | 35 748 |
| Change | +0.40% | -1.19% | +4.80% | +3.44% |
| Opening | 2.50 | 2.53 | 2.54 | 2.64 |
| High | 2.57 | 2.53 | 2.77 | 2.75 |
| Low | 2.50 | 2.40 | 2.53 | 2.58 |
Performance
| 1 day | +3.44% | ||
| 1 week | +3.04% | ||
| Current month | +7.54% | ||
| 1 month | -4.24% | ||
| 3 months | +28.44% | ||
| 6 months | -16.87% | ||
| Current year | +16.31% | ||
| 1 year | -65.95% | ||
| 3 years | -95.77% |
Volumes
marketsDaily volume
35 748
Estimated daily volume
35 748
Avg. Volume 20 sessions
59 694
Daily volume ratio
0.60
Avg. Volume 20 sessions USD
161 770.74
Record volume 1
39 890 690
Record volume 2
19 821 091
Record volume 3
2 410 015
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (USD)
38 207 986
Net sales (USD)
424 000
Number of employees
10
Sales / Employee (USD)
42 400
Free-Float
91.31 %
Free-Float capitalization (USD)
34 889 176
Average Daily Capital Traded
0.42%
Highs and lows
1 week
2.40
2.77
1 month
2.243.02
Current year
1.673.17
1 year
1.678.73
3 years
1.6776.32
5 years
1.67291.60
10 years
1.67291.60
Indicators
Moving average 5 days
2.58
Moving average 20 days
2.55
Moving average 50 days
2.47
Moving average 100 days
2.33
Price spread / (MMA5)
-4.87%
Price spread / (MMA20)
-6.07%
Price spread / (MMA50)
-8.77%
Price spread / (MMA100)
-13.89%
STIM
RSI 9 days
55.64
RSI 14 days
53.61
Sector Comparison - Other Pharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +3.44% | +3.04% | +16.31% | -65.95% | 38.21M | ||
| +4.31% | +4.00% | +31.52% | +79.21% | 690B | ||
| +1.70% | -4.01% | +24.11% | +51.20% | 546B | ||
| -0.46% | +1.20% | -5.21% | -8.67% | 358B | ||
| +0.04% | -1.96% | +17.02% | +8.40% | 323B | ||
| -0.65% | +0.75% | +5.01% | +9.93% | 287B | ||
| -0.22% | -0.10% | +13.68% | +1.14% | 235B | ||
| +0.27% | -0.66% | +4.23% | -5.60% | 199B | ||
| +0.21% | -0.63% | -10.35% | -22.84% | 195B | ||
| -3.79% | +8.36% | +3.98% | +26.61% | 161B | ||
| +1.26% | +9.83% | -2.19% | -26.84% | 159B | ||
| -0.20% | -2.35% | +1.26% | -9.35% | 122B | ||
| -0.20% | -1.66% | -14.44% | -35.57% | 88.99B | ||
| +0.56% | +4.45% | +20.50% | +20.83% | 88.87B | ||
| +1.17% | -0.61% | -19.10% | -17.82% | 81.73B | ||
| -3.24% | -0.75% | +37.50% | +16.63% | 68.52B | ||
| Average | +0.28% | +2.32% | +7.74% | +1.33% | ||
| Weighted average by Cap. | +0.22% | +1.25% | +12.22% | +21.38% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
7d4.IoDhTuw7wmmWKco1h18aSw-xzMB86iSsAEOFPQn_T38.bMaFF6gIiR2mTIsF6WdZM2D5j4Y7rHOadirPVlumI0135tF3o3C0CtlPuQ
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 03:59:31 pm | 2.725 | 100 | 26,084 |
| 03:58:46 pm | 2.722 | 100 | 25,984 |
| 03:49:10 pm | 2.7 | 300 | 25,884 |
| 03:49:10 pm | 2.7 | 300 | 25,584 |
| 03:49:10 pm | 2.7 | 200 | 25,284 |
| 03:49:10 pm | 2.7 | 200 | 25,084 |
| 03:49:10 pm | 2.7 | 200 | 24,884 |
| 03:49:10 pm | 2.7 | 200 | 24,684 |
| 03:49:10 pm | 2.71 | 100 | 24,484 |
| 03:49:10 pm | 2.71 | 100 | 24,384 |
Monthly variations
Annual change
| 2024 | +16.31% | ||
| 2023 | -13.70% | ||
| 2022 | -85.29% | ||
| 2021 | -83.86% | ||
| 2020 | -57.98% |
- Stock Market
- Equities
- VYNE Stock
- Quotes VYNE Therapeutics Inc.